ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68 | -31.3% | 33,600 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $99 | +17.9% | 33,600 | 0.0% | 0.01% | +14.3% |
| Q1 2023 | $84 | -15.2% | 33,600 | +8.0% | 0.01% | -22.2% |
| Q4 2022 | $99 | -100.0% | 31,100 | +62.8% | 0.01% | -55.0% |
| Q1 2022 | $258,000 | +3.6% | 19,100 | 0.0% | 0.02% | +5.3% |
| Q4 2021 | $249,000 | +21.5% | 19,100 | -12.6% | 0.02% | +11.8% |
| Q3 2021 | $205,000 | -8.5% | 21,850 | 0.0% | 0.02% | -5.6% |
| Q2 2021 | $224,000 | – | 21,850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |